SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-017572
Filing Date
2019-09-10
Accepted
2019-09-10 09:56:47
Documents
3
Period of Report
2019-09-09
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k090919_emmauslife.htm 8-K 21413
2 PRESS RELEASE DATED SEPTEMBER 10, 2019 f8k090919ex99-1_emmaus.htm EX-99.1 9664
3 GRAPHIC ex99-1_001.jpg GRAPHIC 11238
  Complete submission text file 0001213900-19-017572.txt   48209
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35527 | Film No.: 191084471
SIC: 8090 Services-Misc Health & Allied Services, NEC
Assistant Director 9